FCRL6 expression (log2) was heterogeneous among these cancer types but, in accord with our recent findings (7), lung adenocarcinomas (LUAD), cutaneous melanomas (SKCM), and breast carcinomas (BRCA) were among the tumors with higher median expression levels. This evidence concerns the gene FCRL6 and breast carcinoma.